Patients taking ARAVA should have platelet, white blood cell acheter leflunomide pas de prescription en ligne medecin count and hemoglobin or hematocrit ostaa halvalla leflunomide yossa monitored at baseline and monthly koop goedkope generieke leflunomide online for six months following initiation of therapy and every 6- to weeks thereafter.
Patients taking ARAVA should have platelet, white blood cell count and hemoglobin or hematocrit monitored at online apotheek leflunomide baseline and monthly for six months following initiation of therapy and every 6- to weeks thereafter. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. See Fetal Neonatal Morbidity and Mortality and also Contraindications under Cautions.